MTRAQ-based quantitative analysis combined with peptide fractionation based on cysteinyl peptide enrichment

Jeonghun Yeom, Min Jung Kang, Dongyun Shin, Hyun Kyu Song, Cheolju Lee, Ji Eun Lee

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

In the present study, the fractionation scheme for cysteinyl peptide enrichment (CPE) was combined with the mass differential tags for relative and absolute quantification (mTRAQ) method to reduce sample complexity and increase proteome coverage. Cysteine residues of the proteins were first alkylated using iodoacetyl PEG2-biotin instead of other conventional alkylating agents such as iodoacetamide. After trypsin digestion, amine groups were labeled with mTRAQ, and these labeled peptides were fractionated according to the presence or absence of cysteine residues using avidin-biotin affinity chromatography. With these approaches, we were able to divide the peptides into the two fractions with more than 90% fractionation efficiency for standard protein and MCF7 cell lysate. When the fractionation strategy was applied to colorectal cancer tissue samples, we were able to obtain quantitative information that was consistent with the previous study based on mTRAQ quantification, implying that the cysteine-based fractionation method does not affect mTRAQ quantification. We expect that the mTRAQ-based quantitative analysis combined with peptide fractionation through the CPE strategy would allow for deep-down analysis of proteome samples and ultimately for increasing proteome coverage with simultaneous quantification for biomarker discovery.

Original languageEnglish
Pages (from-to)41-49
Number of pages9
JournalAnalytical Biochemistry
Volume477
DOIs
Publication statusPublished - 2015 May 15

Fingerprint

Fractionation
Proteome
Peptides
Cysteine
Chemical analysis
Biotin
Iodoacetamide
Affinity chromatography
Avidin
Alkylating Agents
MCF-7 Cells
Biomarkers
Affinity Chromatography
Trypsin
Amines
Digestion
Colorectal Neoplasms
Proteins
Tissue

Keywords

  • Cysteinyl peptide enrichment
  • Mass spectrometry
  • Peptide fractionation
  • Quantification

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology
  • Cell Biology

Cite this

MTRAQ-based quantitative analysis combined with peptide fractionation based on cysteinyl peptide enrichment. / Yeom, Jeonghun; Kang, Min Jung; Shin, Dongyun; Song, Hyun Kyu; Lee, Cheolju; Lee, Ji Eun.

In: Analytical Biochemistry, Vol. 477, 15.05.2015, p. 41-49.

Research output: Contribution to journalArticle

Yeom, Jeonghun ; Kang, Min Jung ; Shin, Dongyun ; Song, Hyun Kyu ; Lee, Cheolju ; Lee, Ji Eun. / MTRAQ-based quantitative analysis combined with peptide fractionation based on cysteinyl peptide enrichment. In: Analytical Biochemistry. 2015 ; Vol. 477. pp. 41-49.
@article{d10267dd9d0f4df6bd23569d423c6593,
title = "MTRAQ-based quantitative analysis combined with peptide fractionation based on cysteinyl peptide enrichment",
abstract = "In the present study, the fractionation scheme for cysteinyl peptide enrichment (CPE) was combined with the mass differential tags for relative and absolute quantification (mTRAQ) method to reduce sample complexity and increase proteome coverage. Cysteine residues of the proteins were first alkylated using iodoacetyl PEG2-biotin instead of other conventional alkylating agents such as iodoacetamide. After trypsin digestion, amine groups were labeled with mTRAQ, and these labeled peptides were fractionated according to the presence or absence of cysteine residues using avidin-biotin affinity chromatography. With these approaches, we were able to divide the peptides into the two fractions with more than 90{\%} fractionation efficiency for standard protein and MCF7 cell lysate. When the fractionation strategy was applied to colorectal cancer tissue samples, we were able to obtain quantitative information that was consistent with the previous study based on mTRAQ quantification, implying that the cysteine-based fractionation method does not affect mTRAQ quantification. We expect that the mTRAQ-based quantitative analysis combined with peptide fractionation through the CPE strategy would allow for deep-down analysis of proteome samples and ultimately for increasing proteome coverage with simultaneous quantification for biomarker discovery.",
keywords = "Cysteinyl peptide enrichment, Mass spectrometry, Peptide fractionation, Quantification",
author = "Jeonghun Yeom and Kang, {Min Jung} and Dongyun Shin and Song, {Hyun Kyu} and Cheolju Lee and Lee, {Ji Eun}",
year = "2015",
month = "5",
day = "15",
doi = "10.1016/j.ab.2015.03.005",
language = "English",
volume = "477",
pages = "41--49",
journal = "Analytical Biochemistry",
issn = "0003-2697",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - MTRAQ-based quantitative analysis combined with peptide fractionation based on cysteinyl peptide enrichment

AU - Yeom, Jeonghun

AU - Kang, Min Jung

AU - Shin, Dongyun

AU - Song, Hyun Kyu

AU - Lee, Cheolju

AU - Lee, Ji Eun

PY - 2015/5/15

Y1 - 2015/5/15

N2 - In the present study, the fractionation scheme for cysteinyl peptide enrichment (CPE) was combined with the mass differential tags for relative and absolute quantification (mTRAQ) method to reduce sample complexity and increase proteome coverage. Cysteine residues of the proteins were first alkylated using iodoacetyl PEG2-biotin instead of other conventional alkylating agents such as iodoacetamide. After trypsin digestion, amine groups were labeled with mTRAQ, and these labeled peptides were fractionated according to the presence or absence of cysteine residues using avidin-biotin affinity chromatography. With these approaches, we were able to divide the peptides into the two fractions with more than 90% fractionation efficiency for standard protein and MCF7 cell lysate. When the fractionation strategy was applied to colorectal cancer tissue samples, we were able to obtain quantitative information that was consistent with the previous study based on mTRAQ quantification, implying that the cysteine-based fractionation method does not affect mTRAQ quantification. We expect that the mTRAQ-based quantitative analysis combined with peptide fractionation through the CPE strategy would allow for deep-down analysis of proteome samples and ultimately for increasing proteome coverage with simultaneous quantification for biomarker discovery.

AB - In the present study, the fractionation scheme for cysteinyl peptide enrichment (CPE) was combined with the mass differential tags for relative and absolute quantification (mTRAQ) method to reduce sample complexity and increase proteome coverage. Cysteine residues of the proteins were first alkylated using iodoacetyl PEG2-biotin instead of other conventional alkylating agents such as iodoacetamide. After trypsin digestion, amine groups were labeled with mTRAQ, and these labeled peptides were fractionated according to the presence or absence of cysteine residues using avidin-biotin affinity chromatography. With these approaches, we were able to divide the peptides into the two fractions with more than 90% fractionation efficiency for standard protein and MCF7 cell lysate. When the fractionation strategy was applied to colorectal cancer tissue samples, we were able to obtain quantitative information that was consistent with the previous study based on mTRAQ quantification, implying that the cysteine-based fractionation method does not affect mTRAQ quantification. We expect that the mTRAQ-based quantitative analysis combined with peptide fractionation through the CPE strategy would allow for deep-down analysis of proteome samples and ultimately for increasing proteome coverage with simultaneous quantification for biomarker discovery.

KW - Cysteinyl peptide enrichment

KW - Mass spectrometry

KW - Peptide fractionation

KW - Quantification

UR - http://www.scopus.com/inward/record.url?scp=84964253398&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964253398&partnerID=8YFLogxK

U2 - 10.1016/j.ab.2015.03.005

DO - 10.1016/j.ab.2015.03.005

M3 - Article

VL - 477

SP - 41

EP - 49

JO - Analytical Biochemistry

JF - Analytical Biochemistry

SN - 0003-2697

ER -